BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 35390032)

  • 1. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections.
    Sarker B; Rahaman MM; Islam MA; Alamin MH; Husain MM; Ferdousi F; Ahsan MA; Mollah MNH
    PLoS One; 2023; 18(3):e0281981. PubMed ID: 36913345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
    Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
    Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
    Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
    Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genetic biomarkers, drug targets and agents for respiratory diseases utilising integrated bioinformatics approaches.
    Ahmed FF; Das AD; Sumi MJ; Islam MZ; Rahman MS; Rashid MH; Alyami SA; Alotaibi N; Azad AKM; Moni MA
    Sci Rep; 2023 Nov; 13(1):19072. PubMed ID: 37925496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing.
    Islam MA; Kibria MK; Hossen MB; Reza MS; Tasmia SA; Tuly KF; Mosharof MP; Kabir SR; Kabir MH; Mollah MNH
    Sci Rep; 2023 Mar; 13(1):4685. PubMed ID: 36949176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents.
    Horaira MA; Islam MA; Kibria MK; Alam MJ; Kabir SR; Mollah MNH
    BMC Med Genomics; 2023 Mar; 16(1):64. PubMed ID: 36991484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
    Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
    Front Immunol; 2022; 13():918692. PubMed ID: 36059456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFI44 is an immune evasion biomarker for SARS-CoV-2 and
    Zheng Q; Wang D; Lin R; Lv Q; Wang W
    Front Immunol; 2022; 13():1013322. PubMed ID: 36189314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.
    Reza MS; Hossen MA; Harun-Or-Roshid M; Siddika MA; Kabir MH; Mollah MNH
    Discov Oncol; 2022 Aug; 13(1):79. PubMed ID: 35994213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis.
    Mosharaf MP; Reza MS; Gov E; Mahumud RA; Mollah MNH
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer.
    Tuly KF; Hossen MB; Islam MA; Kibria MK; Alam MS; Harun-Or-Roshid M; Begum AA; Hasan S; Mahumud RA; Mollah MNH
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893423
    [No Abstract]   [Full Text] [Related]  

  • 13. Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach.
    Zhang H; Feng T
    Biochem Genet; 2023 Apr; 61(2):471-505. PubMed ID: 36104591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Network-Based Bioinformatics Approach to Identify Molecular Biomarkers for Type 2 Diabetes that Are Linked to the Progression of Neurological Diseases.
    Rahman MH; Peng S; Hu X; Chen C; Rahman MR; Uddin S; Quinn JMW; Moni MA
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32041280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential microRNA expression in the peripheral blood from human patients with COVID-19.
    Li C; Hu X; Li L; Li JH
    J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.
    Kim WR; Park EG; Kang KW; Lee SM; Kim B; Kim HS
    Mol Cells; 2020 Nov; 43(11):953-963. PubMed ID: 33199671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.
    MotieGhader H; Safavi E; Rezapour A; Amoodizaj FF; Iranifam RA
    Sci Rep; 2021 Nov; 11(1):21872. PubMed ID: 34750486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
    Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
    Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
    Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
    BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.
    Arisan ED; Dart A; Grant GH; Arisan S; Cuhadaroglu S; Lange S; Uysal-Onganer P
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32512929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.